Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Saved in:
Bibliographic Details
Title: Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
Authors: Bleve S; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Ravera F; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy., Rodrigues S; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Pederzoli F; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Pakula H; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Brighi N; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Giunta EF; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Schepisi G; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Virga A; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gurioli G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Burgio SL; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Fanelli GN; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; First Division of Pathology, Pisa University Hospital, Pisa, Italy., Butler LM; South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia.; South Australian Immunogenomics Cancer Institute & Freemasons Centre for Male Health and Well-Being, Adelaide University, North Terrace, Adelaide, SA, Australia., Nanus DM; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, Leuven Cancer Institute (LKI) and Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA., Lolli C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Experimental Medicine, University of Salento, Fazzi Hospital, Lecce, Italy., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA. mloda@med.cornell.edu.; Nuffield Department of Surgical Sciences, Lincoln College, University of Oxford, Oxford, UK. mloda@med.cornell.edu.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. mloda@med.cornell.edu.
Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2026 Mar 13. Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41820670
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bleve+S%22">Bleve S</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ravera+F%22">Ravera F</searchLink>; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Rodrigues+S%22">Rodrigues S</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pederzoli+F%22">Pederzoli F</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pakula+H%22">Pakula H</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Brighi+N%22">Brighi N</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Giunta+EF%22">Giunta EF</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Schepisi+G%22">Schepisi G</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Virga+A%22">Virga A</searchLink>; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Gurioli+G%22">Gurioli G</searchLink>; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Burgio+SL%22">Burgio SL</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Fanelli+GN%22">Fanelli GN</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; First Division of Pathology, Pisa University Hospital, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Butler+LM%22">Butler LM</searchLink>; South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia.; South Australian Immunogenomics Cancer Institute & Freemasons Centre for Male Health and Well-Being, Adelaide University, North Terrace, Adelaide, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Nanus+DM%22">Nanus DM</searchLink>; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Swinnen+JV%22">Swinnen JV</searchLink>; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, Leuven Cancer Institute (LKI) and Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lolli+C%22">Lolli C</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+U%22">De Giorgi U</searchLink>; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Experimental Medicine, University of Salento, Fazzi Hospital, Lecce, Italy.<br /><searchLink fieldCode="AU" term="%22Loda+M%22">Loda M</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA. mloda@med.cornell.edu.; Nuffield Department of Surgical Sciences, Lincoln College, University of Oxford, Oxford, UK. mloda@med.cornell.edu.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. mloda@med.cornell.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229815755%22">Prostate cancer and prostatic diseases</searchLink> [Prostate Cancer Prostatic Dis] 2026 Mar 13. <i>Date of Electronic Publication: </i>2026 Mar 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9815755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5608 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213657852%22">13657852 </searchLink><i>NLM ISO Abbreviation: </i>Prostate Cancer Prostatic Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41820670
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41391-026-01100-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bleve S
      – PersonEntity:
          Name:
            NameFull: Ravera F
      – PersonEntity:
          Name:
            NameFull: Rodrigues S
      – PersonEntity:
          Name:
            NameFull: Pederzoli F
      – PersonEntity:
          Name:
            NameFull: Pakula H
      – PersonEntity:
          Name:
            NameFull: Brighi N
      – PersonEntity:
          Name:
            NameFull: Giunta EF
      – PersonEntity:
          Name:
            NameFull: Schepisi G
      – PersonEntity:
          Name:
            NameFull: Virga A
      – PersonEntity:
          Name:
            NameFull: Gurioli G
      – PersonEntity:
          Name:
            NameFull: Burgio SL
      – PersonEntity:
          Name:
            NameFull: Fanelli GN
      – PersonEntity:
          Name:
            NameFull: Butler LM
      – PersonEntity:
          Name:
            NameFull: Nanus DM
      – PersonEntity:
          Name:
            NameFull: Swinnen JV
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Lolli C
      – PersonEntity:
          Name:
            NameFull: De Giorgi U
      – PersonEntity:
          Name:
            NameFull: Loda M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2026 Mar 13
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5608
          Titles:
            – TitleFull: Prostate cancer and prostatic diseases
              Type: main
ResultId 1